Tissue-Specific Differences in the Development of Insulin Resistance in a Mouse Model for Type 1 Diabetes

Although insulin resistance is known to underlie type 2 diabetes, its role in the development of type 1 diabetes has been gaining increasing interest. In a model of type 1 diabetes, the nonobese diabetic (NOD) mouse, we found that insulin resistance driven by lipid- and glucose-independent mechanisms is already present in the liver of prediabetic mice. Hepatic insulin resistance is associated with a transient rise in mitochondrial respiration followed by increased production of lipid peroxides and c-Jun N-terminal kinase activity. At the onset of diabetes, increased adipose tissue lipolysis promotes myocellular diacylglycerol accumulation. This is paralleled by increased myocellular protein kinase C θ activity and serum fetuin A levels. Muscle mitochondrial oxidative capacity is unchanged at the onset but decreases at later stages of diabetes. In conclusion, hepatic and muscle insulin resistance manifest at different stages and involve distinct cellular mechanisms during the development of diabetes in the NOD mouse.

[1]  M. Roden,et al.  Reduction of non-esterified fatty acids improves insulin sensitivity and lowers oxidative stress, but fails to restore oxidative capacity in type 2 diabetes: a randomised clinical trial , 2014, Diabetologia.

[2]  G. Shulman,et al.  Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo , 2013, Proceedings of the National Academy of Sciences.

[3]  A. Goustin,et al.  Ahsg-fetuin blocks the metabolic arm of insulin action through its interaction with the 95-kD β-subunit of the insulin receptor. , 2013, Cellular signalling.

[4]  N. Stefan,et al.  Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans , 2013, Nature Medicine.

[5]  S. Mukhopadhyay,et al.  Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance , 2012, Nature Medicine.

[6]  Tasneem S. Ansari,et al.  Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice , 2011, Journal of visualized experiments : JoVE.

[7]  M. Wolzt,et al.  Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes , 2011, Journal of internal medicine.

[8]  Ewald Moser,et al.  Liver ATP Synthesis Is Lower and Relates to Insulin Sensitivity in Patients With Type 2 Diabetes , 2011, Diabetes Care.

[9]  B. Knebel,et al.  Phosphorylation of sterol regulatory element-binding protein (SREBP)-1a links growth hormone action to lipid metabolism in hepatocytes. , 2010, Atherosclerosis.

[10]  B. Viollet,et al.  AMP-activated Protein Kinase α2 Subunit Is Required for the Preservation of Hepatic Insulin Sensitivity by n-3 Polyunsaturated Fatty Acids , 2010, Diabetes.

[11]  G. Shulman,et al.  Diacylglycerol-mediated insulin resistance , 2010, Nature Medicine.

[12]  Ewald Moser,et al.  Abnormal hepatic energy homeostasis in type 2 diabetes , 2009, Hepatology.

[13]  Hui-yu Liu,et al.  Insulin Is a Stronger Inducer of Insulin Resistance than Hyperglycemia in Mice with Type 1 Diabetes Mellitus (T1DM)* , 2009, The Journal of Biological Chemistry.

[14]  T. Wilkin,et al.  The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes , 2009, International Journal of Obesity.

[15]  Hui-yu Liu,et al.  Prolonged Exposure to Insulin Suppresses Mitochondrial Production in Primary Hepatocytes* , 2009, Journal of Biological Chemistry.

[16]  P. Neufer,et al.  Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. , 2009, The Journal of clinical investigation.

[17]  M. Honda,et al.  Obesity Upregulates Genes Involved in Oxidative Phosphorylation in Livers of Diabetic Patients , 2008, Obesity.

[18]  R. Muniyappa,et al.  Comparison between surrogate indexes of insulin sensitivity/resistance and hyperinsulinemic euglycemic clamp estimates in rats. , 2008, American journal of physiology. Endocrinology and metabolism.

[19]  P. Bénit,et al.  Targeted Deletion of AIF Decreases Mitochondrial Oxidative Phosphorylation and Protects from Obesity and Diabetes , 2007, Cell.

[20]  D. Mukhopadhyay,et al.  Effect of Insulin Deprivation on Muscle Mitochondrial ATP Production and Gene Transcript Levels in Type 1 Diabetic Subjects , 2007, Diabetes.

[21]  J. Miyazaki,et al.  Activating Fcγ Receptors Participate in the Development of Autoimmune Diabetes in NOD Mice1 , 2007, The Journal of Immunology.

[22]  M. Birnbaum,et al.  Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator , 2007, Nature.

[23]  Eric Ravussin,et al.  Calorie Restriction Increases Muscle Mitochondrial Biogenesis in Healthy Humans , 2007, PLoS medicine.

[24]  E. Rosen,et al.  FSTL3 deletion reveals roles for TGF-β family ligands in glucose and fat homeostasis in adults , 2007, Proceedings of the National Academy of Sciences.

[25]  P. Scifo,et al.  Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes , 2005, Diabetologia.

[26]  Mingui Fu,et al.  A Nuclear Receptor Atlas: 3T3-L1 adipogenesis. , 2005, Molecular endocrinology.

[27]  M. Roden,et al.  Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes , 2005, International Journal of Obesity.

[28]  L. E. Hammond,et al.  Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice. , 2005, Cell metabolism.

[29]  M. Danna,et al.  Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. , 2003, American journal of physiology. Endocrinology and metabolism.

[30]  H. Eldar-Finkelman,et al.  Increased glucose uptake promotes oxidative stress and PKC-delta activation in adipocytes of obese, insulin-resistant mice. , 2003, American journal of physiology. Endocrinology and metabolism.

[31]  K. Nair,et al.  Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. Gale.  The rise of childhood type 1 diabetes in the 20th century. , 2002, Diabetes.

[33]  J. Yanovski,et al.  Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. , 2002, Diabetes care.

[34]  Jing He,et al.  Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. , 2002, Diabetes.

[35]  F. Homo-Delarche,et al.  Nonobese Diabetic (NOD) Mouse Dendritic Cells Stimulate Insulin Secretion by Prediabetic Islets , 2002, Autoimmunity.

[36]  K. Petersen,et al.  Mechanism of impaired insulin-stimulated muscle glucose metabolism in subjects with insulin-dependent diabetes mellitus. , 1997, The Journal of clinical investigation.

[37]  K. Petersen,et al.  Mechanism of free fatty acid-induced insulin resistance in humans. , 1996, The Journal of clinical investigation.

[38]  L. Rossetti.  Glucose toxicity: the implications of hyperglycemia in the pathophysiology of diabetes mellitus. , 1995, Clinical and investigative medicine. Medecine clinique et experimentale.

[39]  M. Mueckler,et al.  Defect in insulin action on expression of the muscle/adipose tissue glucose transporter gene in skeletal muscle of type 1 diabetic patients. , 1992, The Journal of clinical endocrinology and metabolism.

[40]  H. Yki-Jărvinen,et al.  Mechanisms of Hyperglycemia-Induced Insulin Resistance in Whole Body and Skeletal Muscle of Type I Diabetic Patients , 1992, Diabetes.

[41]  O. Blondel,et al.  In vivo insulin resistance in streptozotocin-diabetic rats — evidence for reversal following oral vanadate treatment , 1989, Diabetologia.

[42]  A. Hruszkewycz.  Evidence for mitochondrial DNA damage by lipid peroxidation. , 1988, Biochemical and biophysical research communications.

[43]  R. DeFronzo,et al.  Hepatic and peripheral insulin resistance following streptozotocin-induced insulin deficiency in the dog. , 1985, Metabolism: clinical and experimental.

[44]  Y. Tochino,et al.  Breeding of a non-obese, diabetic strain of mice. , 1980, Jikken dobutsu. Experimental animals.

[45]  K. Yagi,et al.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. , 1979, Analytical biochemistry.

[46]  R. Steele,et al.  INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.

[47]  M. Rewers,et al.  The importance of palmitoleic acid to adipocyte insulin resistance and whole-body insulin sensitivity in type 1 diabetes. , 2013, The Journal of clinical endocrinology and metabolism.

[48]  Jihyun Song,et al.  Coupling mitochondrial dysfunction to endoplasmic reticulum stress response: a molecular mechanism leading to hepatic insulin resistance. , 2009, Cellular signalling.

[49]  R. Muniyappa,et al.  Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice. , 2008, American journal of physiology. Endocrinology and metabolism.

[50]  J. Miyazaki,et al.  Activating Fc gamma receptors participate in the development of autoimmune diabetes in NOD mice. , 2007, Journal of immunology.

[51]  S. Summers,et al.  Ceramides in insulin resistance and lipotoxicity. , 2006, Progress in lipid research.

[52]  M. Brennan,et al.  The effect of prolonged hyperglycemia on metabolic alterations in the subtotally pancreatectomized rat , 2005, Surgery Today.